Pharmaceuticals News and Research

RSS

Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.

12 Apr 2010

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.

12 Apr 2010

Hospira's proposed merger and loan agreements better than MPI's, says Javelin Pharmaceuticals

Javelin Pharmaceuticals, Inc. announced today that it had received a binding offer from Hospira, Inc. and its wholly-owned subsidiary, Discus Acquisition Corporation ("Discus"), to enter into a merger agreement, a loan and security agreement and intellectual property security agreements whereby Discus will, subject to certain conditions, commence an all cash tender offer to acquire all of the outstanding shares of Javelin at a per share price of $2.20.

12 Apr 2010

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

12 Apr 2010

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Global 360, a leading provider of Process and Document Management solutions, today announced that Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, has chosen Global 360 to improve how critical reports and images are communicated and reported to its customers. In the process, the company will also save thousands on courier costs, satisfy a "going green" initiative, and mitigate risk, helping satisfy auditors and regulators.

12 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

12 Apr 2010

Carestream Molecular Imaging, OncoVision sign exclusive agreement for Albira PET/SPECT/CT imaging system

Carestream Molecular Imaging, a division of Carestream Health, Inc., has signed an exclusive, multi-year worldwide agreement with OncoVision (Valencia, Spain), to sell, market and service the Albira PET/SPECT/CT imaging system for small animal research. With the addition of this innovative, multimodal imaging system, Carestream Molecular Imaging will offer the broadest portfolio of pre-clinical in vivo imaging modalities in the market.

12 Apr 2010

Over 12,000 participants already registered for 25th Anniversary EAU Congress

The upcoming 25th Anniversary EAU Congress in Barcelona from April 16 to 20 promises to be one of the EAU's biggest meetings in recent years with around 12,100 participants already registered to attend the annual urological event.

12 Apr 2010

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.

12 Apr 2010

CoreLab Partners' new logo and brand identity launched

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.

12 Apr 2010

AB SCIEX announces formal opening of Asia Pacific Application Support Center in Shanghai

AB SCIEX, a global leader in life science analytical technologies, today announced the formal opening of its Asia Pacific Application Support Center in Shanghai. With state-of-the-art, award-winning facilities, the new Application Support Center serves as a regional center of excellence for comprehensive service, support and application development to enable the science community in China and the region to continue its increasing use of mass spectrometry and complementary technologies for a broad range of applications.

12 Apr 2010

New patient education video and guidebook for MS patients

Silver screen star Teri Garr is the host of the American Academy of Neurology Foundation's newest patient education video and guidebook, Living Well: A Guide to Managing Multiple Sclerosis for Patients and Families.

12 Apr 2010

UCCS, Texas A&M Health Science Center announce collaboration in bioenergetics, immunology and cell life

The University of Colorado at Colorado Springs will work collaboratively with the Texas A&M Health Science Center in the areas of bioenergetics, immunology and cell life, according to a memorandum of understanding between the two schools announced Monday, April 10.

12 Apr 2010

BioClinica to showcase expanded suite of services at upcoming global industry conferences

BioClinica, Inc., a leading provider of clinical trial management services will participate in, and present at, key industry conferences during April and May. Principal members of the BioClinica team will participate as expert panelists as well as demonstrate the value of the Company's expanded suite of services at these conferences.

From Clario 12 Apr 2010

Aptium Oncology Myeloma Consortium launched

Aptium Oncology, Inc. today announced the launch of Aptium Oncology Myeloma Consortium (AMyC), a broad-based collaboration that brings together renowned investigators to work with pharmaceutical sponsors to advance clinical and translational research in myeloma and related cancers.

12 Apr 2010

BeaconEquity.com releases investment report on Cord Blood America

BeaconEquity.com announces an investment report featuring umbilical cord blood stem cell preservation company Cord Blood America. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

12 Apr 2010

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Affinium Pharmaceuticals announced today the commencement of a Phase I study in the United States for its novel molecular entity, AFN-1252, a first in class antibiotic candidate focused on the oral and IV treatment of susceptible and highly resistant strains of Staphylococcus aureus.

12 Apr 2010

Sun Pharmaceutical Industries' generic Namenda ANDA: USFDA grants tentative approval

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.

12 Apr 2010

ChemImage recieves patent for chemical imaging explosives optical sensor

ChemImage Corporation announced today the receipt of its 100th U.S. patent, number 7,692,776 for a chemical imaging explosives optical sensor that detects explosive compounds.

12 Apr 2010

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

12 Apr 2010

Pharmaceuticals News and Research

Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

Hospira's proposed merger and loan agreements better than MPI's, says Javelin Pharmaceuticals

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Carestream Molecular Imaging, OncoVision sign exclusive agreement for Albira PET/SPECT/CT imaging system

Over 12,000 participants already registered for 25th Anniversary EAU Congress

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

CoreLab Partners' new logo and brand identity launched

AB SCIEX announces formal opening of Asia Pacific Application Support Center in Shanghai

New patient education video and guidebook for MS patients

UCCS, Texas A&M Health Science Center announce collaboration in bioenergetics, immunology and cell life

BioClinica to showcase expanded suite of services at upcoming global industry conferences

Aptium Oncology Myeloma Consortium launched

BeaconEquity.com releases investment report on Cord Blood America

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Sun Pharmaceutical Industries' generic Namenda ANDA: USFDA grants tentative approval

ChemImage recieves patent for chemical imaging explosives optical sensor

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence